HER2 is a gene (also called HER2/neu) that helps control how cells grow, divide, and repair themselves. About 1 out of 4 breast cancers has too many copies of the HER2 gene. The HER2 gene directs the production of special proteins, called HER2 receptors, in cancer cells. Read research about treatments for women with early-stage cancers that are HER2-positive.
Cancers with too many copies of the HER2 gene or too many HER2 receptors tend to grow fast. They are also associated with an increased risk of spread. But they do respond very well to treatment that works against HER2. This treatment is called anti-HER2 antibody therapy.
There are three tests for HER2-positive cancer:
Find out which HER2 test you had. This is important. Only cancers that test IHC "3+" or FISH or SPoT-Light "positive" will respond well to therapy that works against HER2. An IHC 2+ test result is called borderline. If you have a 2+ result, you can and should ask to have the tissue tested with the FISH or SPoT-Light test.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
Learn more about our commitment to your privacy
© 2009 Breastcancer.org - All rights reserved.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.